|
Hot Stocks
|
Pfizer CEO Albert Bourla… ShowHide Related Items >><< - 04/22/21
- Pfizer declares 39c per share cash dividend, says dividend won't be cut
- 04/22/21
- Zenith Epigenetics enters clinical collaboration with Astellas Pharma
- 04/19/21
- Pfizer, BioNTech to supply additional 100M COVID-19 vaccine doses to EU
- 04/16/21
- U.S. exceeds 200M COVID-19 vaccine doses administered
- 04/19/21
- Pfizer, BioNTech to supply additional 100M COVID-19 vaccine doses to EU
- 04/16/21
- U.S. exceeds 200M COVID-19 vaccine doses administered
- 04/13/21
- Pfizer can deliver 10% more vaccine doses to U.S. by end of May, says CEO
- 04/09/21
- Pfizer, BioNTech seek expansion of vaccine EUA to include 12-15 year olds
- 04/21/21 Citi
- Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
- 04/13/21 Morgan Stanley
- Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
- 04/13/21 JPMorgan
- Vaccine pause 'incremental negative' for J&J, says JPMorgan
- 04/09/21
- Pfizer to host conference call
- 02/23/21 B. Riley Securities
- B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
- 02/01/21 SVB Leerink
- Moderna price target raised to $80 from $69 at SVB Leerink
- 01/29/21 Piper Sandler
- Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
- 01/14/21 Morgan Stanley
- 80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
- 02/02/21
- Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19
- 02/02/21
- Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19
- 02/02/21
- Pfizer reports Q4 adjusted EPS 42c, consensus 48c
- 02/01/21
- Notable companies reporting before tomorrow's open
|
|
On The Fly
| ShowHide Related Items >><< - 04/22/21
- Intel CEO: We are working to rebuild the culture
- 04/21/21
- Luminar jumps 19% after poaching executives from Intel, Tesla
- 04/21/21
- Luminar appoints Alan Prescott as CLO
- 04/12/21
- Intel drops 2% after Nvidia announces first server microprocessors
- 07:06 Today
- American Express reports Q1 Global Merchant, Network Services net income $414M
- 07:05 Today
- American Express reports Q1 Global Consumer Services net income $665M
- 07:04 Today
- American Express reports Q1 Global Consumer Services Group net income $2.1B
- 04/22/21
- Albertsons names Danielle Crop chief data officer
- 10:00 Today
- Snap rises 7.1%
- 09:47 Today
- Snap rises 9.3%
- 04/22/21
- Snap Q2 DAU growth rate to be consistent with Q1
- 04/22/21
- Snap says Q1 revenue and DAU growth rates highest in over three years
- $155.77 /
+10.96 (+7.57%) - 10:05 Today
- Silicon Labs appoints Daniel Cooley as CTO
- 04/22/21
- Silicon Labs jumps 14% to $165 after selling I&A business to Skyworks for $2.75B
- 04/22/21
- Silicon Laboratories trading resumes
- 04/22/21
- Skyworks jumps about 4% to $190.67 after buying Silicon Labs' I&A business
- 04/22/21
- Silicon Labs jumps 14% to $165 after selling I&A business to Skyworks for $2.75B
- 04/22/21
- Skyworks jumps about 4% to $190.67 after buying Silicon Labs' I&A business
- 04/22/21
- Skyworks to buy Infrastructure & Automotive Business of Silicon Labs for $2.75B
- 04/22/21
- Silicon Labs to sell I&A business to Skyworks for $2.75B in cash
- $165.68 /
+0.575 (+0.35%) - 11:37 Today
- CDC says 3 deaths, 7 hospitalized after TTS seen following J&J vaccine
- 04/21/21
- FDA provides feedback from Emergent's Baltimore-Bayview facility inspection
- 04/21/21
- J&J establishing global vaccine supply network after Emergent issues
- 04/21/21
- FDA says completed inspection of Emergent plant, working with company on fixes
- 04/21/21
- Ocugen partner Bharat Biotech reports analysis of Phase 3 study of COVAXIN
- 04/14/21
- Paper published in preprint on Covishield and Covaxin
- 04/14/21
- Ocugen appoints John Paul Gabriel as SVP, manufacturing and supply chain
- 03/03/21
- Ocugen, Bharat Biotech announce Phase 3 interim results of COVAXIN
- 04/22/21
- Independent Bank, Meridian Bancorp sign $1.15B merger agreement
- 03/18/21
- Independent Bank raises quarterly dividend by 4% to 48c per share
- 08:15 Today
- Inovio sinks after Department of Defense stops vaccine trial funding
- 08:05 Today
- Inovio planning for ex-U.S. global Phase 3 trial for INO-4800
- 04/15/21
- Inovio's COVID-19 vaccine candidate shows response against all tested variants
- 03/01/21
- Inovio reports REVEAL 1 trial met primary, secondary endpoints
- 12:00 Today
- Kimberly-Clark falls -5.7%
- 10:00 Today
- Kimberly-Clark falls -5.0%
- 07:41 Today
- Kimberly-Clark drops 5% to $134 after Q1 results miss, FY21 guidance cut
- 07:39 Today
- Kimberly-Clark sees FY21 key cost inputs increasing $900M-$1.05B
- 04/22/21
- Meridian Bancorp trading resumes
- 04/22/21
- Independent Bank, Meridian Bancorp sign $1.15B merger agreement
- 04/22/21
- Meridian Bancorp trading halted, news pending
- 02/24/21
- Meridian Bancorp raises dividend 25%, announces new stock repurchase plan
- 09:05 Today Needham
- Intel price target lowered to $70 from $74 at Needham
- 07:35 Today Morgan Stanley
- Intel report offered 'no big surprises,' says Morgan Stanley
- 04/22/21 Citi
- Intel shares are at near-term peak, says Citi
- 04/21/21 Atlantic Equities
- Apple making push to fight Spotify for podcast creators, says Atlantic Equities
- 04/05/21 Wells Fargo
- American Express price target raised to $165 from $150 at Wells Fargo
- 04/01/21 Morgan Stanley
- American Express price target raised to $166 from $165 at Morgan Stanley
- 02/16/21
- Fly Intel: Top five analyst downgrades
- 02/16/21 Baird
- American Express downgraded at Baird, shares fairly valued here
- 07:51 Today Canaccord
- Snap results suggests momentum is continuing, says Canaccord
- 07:20 Today Barclays
- Snap price target raised to $75 from $66 at Barclays
- 06:54 Today Deutsche Bank
- Snap price target lowered to $72 from $74 at Deutsche Bank
- 06:44 Today KeyBanc
- Snap price target lowered to $80 from $87 at KeyBanc
- $155.77 /
+10.96 (+7.57%) - 10:01 Today
- Fly Intel: Top five analyst upgrades
- 07:46 Today B. Riley
- Skyworks price target raised to $230 from $225 at B. Riley
- 07:19 Today Barclays
- Silicon Labs price target raised to $150 from $140 at Barclays
- 06:29 Today KeyBanc
- Silicon Labs upgraded to Overweight from Sector Weight at KeyBanc
- 07:46 Today B. Riley
- Skyworks price target raised to $230 from $225 at B. Riley
- 04/09/21 Mizuho
- Skyworks price target raised to $207 from $195 at Mizuho
- 03/11/21 Barclays
- Skyworks price target raised to $190 from $185 at Barclays
- 03/11/21 Barclays
- Qorvo upgraded to Overweight from Equal Weight at Barclays
- $165.68 /
+0.575 (+0.35%) - 04/19/21 Chardan
- Chardan sees J&J moving forward with Emergent if observations are minor
- 04/14/21 Guggenheim
- Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
- 04/13/21 Goldman Sachs
- J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
- 04/13/21 Morgan Stanley
- Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
- 04/21/21 Roth Capital
- EUA submission to follow after Ocugen partner COVAXIN results, says Roth Capital
- 03/31/21
- Ocugen participates in a conference call with Cantor Fitzgerald
- 03/16/21 Roth Capital
- Covaxin chances of U.S. approval now increased, says Roth Capital
- 03/04/21 Roth Capital
- Ocugen price target raised to $10 from $9 at Roth Capital
- 12/17/20 Seaport Global
- Seaport Global rolls out coverage of Regional and Community Banks with 4 Buys
- 12/17/20 Seaport Global
- Independent Bank initiated with a Neutral at Seaport Global
- 10/26/20 Compass Point
- Independent Bank upgraded to Buy from Neutral at Compass Point
- 06/24/20 Piper Sandler
- Independent Bank downgraded to Neutral from Overweight at Piper Sandler
- 09:47 Today Piper Sandler
- Piper 'incrementally cautious' on Inovio, says today's selloff appropriate
- 03/23/21
- Fly Intel: Top five analyst initiations
- 03/23/21 BofA
- Inovio initiated with a Neutral at BofA
- 03/02/21 Piper Sandler
- Piper lowers Inovio target to $7 after 'decidedly negative' update
- 04/01/21 B. Riley Securities
- Intrusion's Kimberly-Clark win brings meaningful opportunity, says B. Riley
- 03/19/21 JPMorgan
- Kimberly-Clark downgraded to Underweight from Neutral at JPMorgan
- 01/26/21
- Fly Intel: Top five analyst downgrades
- 01/26/21 Jefferies
- Kimberly-Clark price target raised to $156 from $152 at Jefferies
- 06/17/20 Raymond James
- Meridian Bancorp upgraded to Strong Buy from Outperform at Raymond James
- 06/17/20 Raymond James
- Meridian Bancorp upgraded to Strong Buy from Outperform at Raymond James
- 04/22/21
- Intel sees Q2 EPS $1.05, consensus $1.09
- 04/22/21
- Intel raises FY21 adjusted EPS view to $4.60, consensus $4.58
- 04/22/21
- Intel reports Q1 EPS $1.39, consensus $1.15
- 04/22/21
- Notable companies reporting after market close
- 07:03 Today
- American Express reports Q1 EPS $2.74, consensus $1.61
- 04/22/21
- Notable companies reporting before tomorrow's open
- 04/22/21
- Fly Intel: What to watch in credit card space earnings reports
- 04/22/21
- Notable companies reporting before tomorrow's open
- 04/22/21
- Snap sees Q2 revenue $820M-$840M, consensus $826.11M
- 04/22/21
- Snap reports Q1 adjusted EPS 0c, consensus (5c)
- 04/22/21
- Notable companies reporting after market close
- 02/04/21
- Snap sees Q1 revenue $720M-$740M, consensus $704.57M
- $155.77 /
+10.96 (+7.57%) - 04/22/21
- Silicon Labs sees Q1 revenue $255M, consensus $242.11M
- 02/03/21
- Silicon Labs sees Q1 adjusted EPS 70c-80c, consensus 67c
- 02/03/21
- Silicon Labs reports Q4 adjusted EPS 84c, consensus 73c
- 10/28/20
- Silicon Labs sees Q4 adjusted EPS 68c-78c, consensus 71c
- 01/28/21
- Skyworks sees Q2 adjusted EPS midpoint $2.34, consensus $1.70
- 01/28/21
- Skyworks reports Q1 adjusted EPS $3.36, consensus $2.08
- 01/28/21
- Notable companies reporting after market close
- 11/02/20
- Skyworks sees Q1 EPS $2.06 at midpoint of revenue view, consensus $1.80
- $165.68 /
+0.575 (+0.35%) - 04/20/21
- Johnson & Johnson raises FY21 adjusted EPS view to $9.30-$9.45 from $9.25-$9.45
- 04/20/21
- Johnson & Johnson reports Q1 adjusted EPS 2.59, consensus $2.34
- 04/19/21
- Notable companies reporting before tomorrow's open
- 04/19/21
- Notable companies reporting before tomorrow's open
- 03/18/21
- Ocugen reports 2020 EPS (31c), consensus (33c)
- 11/06/20
- Ocugen reports Q3 EPS (7c), consensus (2c)
- 04/22/21
- Independent Bank Corp. reports Q1 EPS $1.26, consensus $1.09
- 01/21/21
- Independent Bank reports Q4 EPS $1.05, consensus $1.03
- 03/01/21
- Inovio reports Q4 EPS (14c), consensus (22c)
- 11/09/20
- Inovio reports Q3 EPS 11c, consensus (19c)
- 07:36 Today
- Kimberly-Clark cuts FY21 revenue growth view to 3%-5% from 4%-6%
- 07:32 Today
- Kimberly-Clark cuts FY21 adjusted EPS view to $7.30-$7.55 from $7.75-$8.00
- 07:30 Today
- Kimberly-Clark reports Q1 adjusted EPS $1.80, consensus $1.93
- 04/22/21
- Notable companies reporting before tomorrow's open
- 01/26/21
- Meridian Bancorp reports Q4 EPS 36c, consensus 32c
- 10/27/20
- Meridian Bancorp reports Q3 EPS 33c, consensus 27c
|
|
Periodicals
| ShowHide Related Items >><< - 03/16/21
- Exxon Mobil urges shareholders to vote blue card for 12 director nominees
- 03/16/21
- Exxon tells shareholders not to vote for Engine No. 1 nominees
- 03/15/21
- Engine No. 1 releases full slate of nominees for Exxon Mobil board
- 03/03/21
- Exxon Mobil must change direction, not just appoint board candidates, CURE says
- 04/14/21
- Fly Intel: Top five analyst upgrades
- 04/14/21 Raymond James
- Exxon Mobil upgraded to Market Perform from Underperform at Raymond James
- 04/14/21 Raymond James
- Exxon Mobil upgraded to Market Perform from Underperform at Raymond James
- 04/12/21
- Fly Intel: Top five analyst upgrades
- 02/02/21
- Exxon Mobil reports Q4 ex-items EPS 3c, consensus 1c
- 02/01/21
- Notable companies reporting before tomorrow's open
- 02/01/21
- Notable companies reporting before tomorrow's open
- 12/30/20
- Exxon Mobil says Q4 income boosted by up to $600M from gas prices
- 04/22/21
- NYC sues Exxon, BP, Shell over 'cleaner' fuel claims, Reuters reports
- 04/20/21
- Exxon Mobil pitches $10B plan to capture and bury emissions, NY Times reports
- 04/07/21
- Exxon Mobil exploring sale of Advanced Elastomer Systems unit, Reuters says
- 04/05/21
- Exxon files breach of contract suit against Energy Transfer, Reuters says
- 04/07/21
- Fly Intel: Wall Street's top stories for Wednesday
- 03/01/21
- Fly Intel: Wall Street's top stories for Monday
- 03/01/21
- Fly Intel: Wall Street's top stories at midday
- 03/01/21
- Fly Intel: Pre-market Movers
- 03/03/21
- Exxon Mobil call volume above normal and directionally bullish
- 03/01/21
- Unusually active option classes on open March 1st
- 02/09/21
- Unusually active option classes on open February 9th
- 02/08/21
- Exxon Mobil call volume above normal and directionally bullish
|